ClassID:

116693

C12Y302/02022 - CPC Classification

Classification description:

Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2) hydrolysing N-glycosyl compounds (3.2.2) rRNA N-glycosylase (3.2.2.22)

Recent Application in this class:
#1
20260021167
2026-01-22

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING NEURODEGENERATIVE DISEASES

#2
20250313647
2025-10-09

MUTANT AND MISLOCALIZED CELL SURFACE NUCLEOPHOSMIN 1 AS A DIAGNOSTIC AND THERAPEUTIC TARGET OF HUMAN DISEASE

#3
20250243476
2025-07-31

PLANT LECTINS AS CARRIERS OF ASSOCIATED DRUG SUBSTANCES INTO ANIMAL AND HUMAN CELLS

#4
20240409589
2024-12-12

MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES

#5
20240360184
2024-10-31

DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS

#6
20230140157
2023-05-04

Plant lectins as carriers of associated drug substances into animal and human cells

#7
20220306701
2022-09-29

MHC class I epitope delivering polypeptides

#8
20220275030
2022-09-01

De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals

#9
20220220164
2022-07-14

A GENETICALLY ENCODED PROTEIN SYNTHESIS INHIBITOR

#10
20210253648
2021-08-19

MHC class I epitope delivering polypeptides

#11
20210163547
2021-06-03

NOVEL SYSTEMS FOR SCREENING INTERNALIZING ANTIBODY AND USES THEREOF

#12
20210017512
2021-01-21

CELL-TARGETING MOLECULES COMPRISING PROTEASE-CLEAVAGE RESISTANT, SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES AND CARBOXY-TERMINAL MOIETIES

#13
20200062861
2020-02-27

Glycosynthase variants for glycoprotein engineering and methods of use

#14
20190365914
2019-12-05

Antibody-drug conjugates and the use of same in therapy

#15
20190153044
2019-05-23

MHC Class I Epitope Delivering Polypeptides

#16
20190105406
2019-04-11

Antibody-drug conjugates and immunotoxins

#17
20180326088
2018-11-15

COMPOSITIONS AND METHODS FOR TREATING CANCER

#18
20180291359
2018-10-11

CELL-TARGETING MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL, SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS

#19
20180237512
2018-08-23

NOVEL MODULATORS AND METHODS OF USE

#20
20170369574
2017-12-28

AN IMMUNOTOXIN FOR USE IN THE TREATMENT OF LEISHMANIASIS

#21
20170298141
2017-10-19

COMPOSITIONS AND METHODS FOR TREATING CANCER

#22
20170267987
2017-09-21

Plant lectins as carriers of associated drug substances into animal and human cells

#23
20170232115
2017-08-17

POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF

#24
20170182096
2017-06-29

LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS

#25
20170101636
2017-04-13

Cell-targeting molecules comprising protease-cleavage resistant, Shiga toxin A subunit effector polypeptides and carboxy-terminal moieties

#26
20170007716
2017-01-12

Antibody-drug conjugates and immunotoxins

#27
20170007714
2017-01-12

Antibody-drug conjugates and immunotoxins

#28
20160340394
2016-11-24

DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS

#29
20160264653
2016-09-15

Modulators and methods of use

#30
20160257745
2016-09-08

Modulators and methods of use

#31
20160177284
2016-06-23

CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS

#32
20160151515
2016-06-02

Antibody-drug conjugates and the use of same in therapy

#33
20160136297
2016-05-19

Targeting ABCB5 for cancer therapy

#34
20160131639
2016-05-12

Antigen binding protein and its use as addressing product for the treatment of cancer

#35
20160083707
2016-03-24

Plant lectins as carriers of associated drug substances into animal and human cells

#36
20160068829
2016-03-10

ANTIMICROBIAL FUSION COMPOUNDS AND USES THEREOF

#37
20160030529
2016-02-04

TARGETED ELIMINATION OF FACTOR VIII IMMUNE CELLS

#38
20150125445
2015-05-07

COMPOSITIONS AND METHODS FOR TREATING CANCER

#39
20150037340
2015-02-05

Antigen binding protein and its use as addressing product for the treatment of cancer

#40
20110165149
2011-07-07

Targeting ABCB5 for cancer therapy

#41
20090117117
2009-05-07

Targeting ABCB5 for cancer therapy